Anti Radiation Drugs Market Prediction and Analysis Offered By New Study | RxBio Inc., Annova Chem Inc., Medicom Healthcare Ltd

Market Overview:

Anti-radiation drugs are commonly used during cancer radiotherapy to protect healthy cells from the harmful effects of radiation. They help reduce side effects like skin burns, nausea, vomiting and fatigue that patients may experience during radiation therapy.

Market Dynamics:

The global anti-radiation drugs market is expected to witness significant growth during the forecast period owing to increasing demand from cancer patients undergoing radiation therapy. As per WHO, cancer is the second leading cause of death globally and around 10 million deaths were recorded due to cancer in 2020. This rising prevalence of cancer is expected to drive the demand for anti-radiation drugs from 2023-2030. In addition, increasing awareness about management of side effects and growing healthcare expenditure in developing countries are also projected to fuel the market growth over the forecast period.

Receive Sample of Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/6418

Major companies are:

✤ RxBio Inc.
✤ Annova Chem Inc.
✤ Medicom Healthcare Ltd.
✤ Onconova Therapeutics
✤ Genome Protection Inc.
✤ Grace Therapeutics LLC
✤ Amgen Inc.
✤ Partner Therapeutics Inc.
✤ Jubilant Life Sciences Ltd.
✤ Cipla Inc.
✤ Stium Inc.
✤ Soligenix Inc.
✤ Aeolus Pharmaceuticals
✤ PharmaIN Corp
✤ Immune Modulators Inc.

Market Driver 1: Increasing Adoption of Medical Imaging Technologies

The anti-radiation drugs market is witnessing significant growth owing to the rising adoption of medical imaging technologies like X-rays, CT scans, PET scans, etc. across hospitals and diagnostic centers globally. Medical imaging finds widespread applications for disease diagnosis and monitoring treatment responses. However, exposure to ionizing radiation during such procedures can increase the risks of developing cancers and other disorders. This has boosted the demand for anti-radiation drugs that help protect patients and medical staff against harmful effects. With growing awareness about radiation-induced health risks and improving access to advanced healthcare facilities, especially in developing nations, the use of medical imaging is expected to spike in the coming years. This will correspondingly drive the need for anti-radiation pharmaceutical products.

Market Driver 2: Rising Incidence of Cancer Worldwide

The growing global disease burden of cancer has emerged as a key factor stimulating market expansion. Cancer is one of the leading causes of mortality, and according to WHO, its incidence is projected to further increase in the coming decades. Radiotherapy or radiation therapy, which involves carefully measured doses of radiation being targeted at tumors, is a commonly used non-invasive treatment modality for several cancer types. However, exposure to such ionizing radiation can damage normal cells and raise cancer risks. Thus, oncologists often recommend anti-radiation drugs to cancer patients undergoing radiotherapy to minimize harmful side effects. With the patient pool undergoing radiotherapy expanding in sync with the rising cancer prevalence, pharmaceutical firms are witnessing significant uptake of their anti-radiation drugs offering protection from unintended radiation effects. This will continue fueling market revenue growth over the forecast period.

Market Restrain: Stringent Regulations Governing Drug Development and Approval

The global anti-radiation drugs market growth potential faces a restrain from the rigorous regulations surrounding new drug development and approval. Regulatory authorities extensively evaluate pharmaceutical products for efficacy, quality, and safety before approval. Given the risks associated with ionizing radiations, anti-radiation drugs warrant extra scrutiny during clinical trials and regulatory reviews. Moreover, radiation protection is a complex mechanism requiring in-depth understanding of radiation biology. This necessitates extensive R&D investments from manufacturers for new molecule discovery and testing extensively over long duration clinical phases before approval and commercialization. The high costs and timelines involved in compliant product development act as a hindrance, especially for small players. Also, any failures during clinical trials or non-compliance with evolving guidelines can delay or restrict market entry. Therefore, stringent regulatory compliance remains a challenge for this industry.

Market Opportunity: Increasing Use of Anti-Radiation Drugs in Non-Oncology Applications

While cancer and radiotherapy applications have been the major demand generators historically, anti-radiation drugs are increasingly witnessing uptake in non-oncology areas as well. This presents lucrative opportunities for market participants. For instance, anti-radiation drugs find usage in protecting occupational workers involved in industrial radiography, radioactive isotope handling, nuclear medicine procedures, etc. Radioprotectors also help military staff and first responders operating in zones exposed to nuclear/radiological threats. Additionally, during space travel missions, ionizing radiations from galactic cosmic rays and solar particle events raise chronic health risks for astronauts. Pharmaceutical firms are now engaged in trials investigating effectiveness of anti-radiation drugs for countering space radiation exposures during future manned missions.

Purchase Our Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/6418

Key Questions Answered In The Report:

• Which regional market will experience the greatest and most rapid growth?

• Who are the top five Market players?

• How will the Market evolve over the next six years?

• What application and product will dominate the Market?

• What are the market drivers and constraints for Anti Radiation Drugs Market?

• What will be the Market's CAGR and size during the forecast period?

Contact Us

Mr. Shah
Coherent Market Insights Pvt Ltd,
533 Airport Boulevard, Suite 400, Burlingame,
CA 94010, United States
Phone: US +12067016702 / UK +4402081334027
JAPAN:+81-50-5539-1737
INDIA:+91-848-285-0837
Email: sales@coherentmarketinsights.com

About Coherent Market Insights

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

This release was published on openPR.